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A modified version of the solvent extraction method described by Buchet et al (1980) 
for partially speciating arsenic in human urine specimens was investigated. It was shown 
to be a valid means of isolating those arsenicals associated with toxicity and was used to 
screen subjects with elevated total urinary arsenic levels for toxic arsenicals. This 
method involves the removal of the toxic arsenicals arsenite (AsIII), arsenate (AsV
 
), 
methanearsonic acid (MAA) and dimethylarsinic acid (DMAA) from urine by a solvent 
extraction process. After the addition of concentrated hydrochloric acid and potassium 
iodide, toxic arsenicals are extracted from the urine into cyclohexane and mixed with a 
matrix modifier solution of nickel nitrate for analysis by graphite furnace atomic 
absorption spectrometry (GFAAS). Since, in most subjects, elevated urinary total 
arsenic levels are due to the presence of non-toxic arsenicals following seafood 
consumption, partial speciation by solvent extraction / GFAAS is used to confirm or to 
rule out arsenic poisoning in subjects with elevated total urinary arsenic levels. 
A capillary electrophoresis (CE) technique was developed, in which CE was interfaced 
with an inductively coupled plasma mass spectrometer (ICPMS) to permit the isolation 
and estimation of major arsenic species in urine and other biological specimens. It was 
possible to separate 5 arsenicals by CE and to detect, by coupled ICPMS, levels of 
individual arsenicals corresponding to 0.1 ppm (1.3 µmol/L) arsenic in urine. This 
CE / ICPMS technique was used to evaluate partial speciation by solvent 
extraction / GFAAS in a range of artificially prepared standard mixtures of arsenicals, 
and in urine specimens. It was confirmed that the latter technique is a valid means of 
assessing subjects suspected of arsenic poisoning because of their elevated total urinary 
arsenic levels. 
 
Using the CE / ICPMS technique, it was also confirmed in one leukaemic patient, that, 
in humans, the main urinary arsenicals excreted after acute exposure to arsenite (AsIII) 
are DMAA and MAA. In other healthy subjects, it was found that, after seafood 
consumption, the predominant arsenical present in urine was arsenobetaine. On the basis 
of these studies, a protocol was defined for the stepwise investigation of urine 





Preliminary studies were also carried out on edible seaweeds, which are known to 
contain arsenosugars and arsenolipids. Partial speciation, of edible seaweed digests, 
gave incomplete and variable arsenic recoveries. When the same digests were analysed 
by CE / ICPMS, the only arsenical found was arsenobetaine, suggesting that 
arsenosugars and arsenolipids may have been broken down to form arsenobetaine during 
extraction. Although inconclusive, these results demonstrate the usefulness of 
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